# FDA Inspection 775234 - Damien Sanderlin, MD - March 29, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/damien-sanderlin-md/b6ee764f-53bb-4b09-935f-ca1c0faf0102/
Source feed: FDA_Inspections

> FDA Inspection 775234 for Damien Sanderlin, MD on March 29, 2012. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 775234
- Company Name: Damien Sanderlin, MD
- Inspection Date: 2012-03-29
- Classification: Official Action Indicated (OAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 790026 - 2012-07-18](https://www.globalkeysolutions.net/api/records/fda_inspections/damien-sanderlin-md/c0ef4d71-a730-4bf1-b9f9-ba6dc73fb184/)

Company: https://www.globalkeysolutions.net/companies/damien-sanderlin-md/ee882a7a-e0f5-4507-a51a-8796cab9d12f

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d